Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Magnetic resonance imaging-guided targeted prostate biopsy: Comparison between computer-software-based fusion versus cognitive fusion technique in biopsy-naïve patients.

Yamada Y, Shiraishi T, Ueno A, Ueda T, Fujihara A, Naitoh Y, Hongo F, Ukimura O.

Int J Urol. 2019 Oct 6. doi: 10.1111/iju.14127. [Epub ahead of print]

PMID:
31587386
2.

Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies.

Sakakida T, Ishikawa T, Chihara Y, Harita S, Uchino J, Tabuchi Y, Komori S, Asai J, Narukawa T, Arai A, Tsunezuka H, Kosuga T, Konishi H, Moriguchi M, Yasuda H, Hongo F, Inoue M, Hirano S, Ukimura O, Itoh Y, Taguchi T, Takayama K.

Clin Transl Oncol. 2019 Oct 1. doi: 10.1007/s12094-019-02214-8. [Epub ahead of print]

PMID:
31576495
3.

Clinical features of immune-related thyroid dysfunction and its association with outcomes in patients with advanced malignancies treated by PD-1 blockade.

Sakakida T, Ishikawa T, Uchino J, Chihara Y, Komori S, Asai J, Narukawa T, Arai A, Kobayashi T, Tsunezuka H, Kosuga T, Konishi H, Hongo F, Inoue M, Hirano S, Ukimura O, Itoh Y, Taguchi T, Takayama K.

Oncol Lett. 2019 Aug;18(2):2140-2147. doi: 10.3892/ol.2019.10466. Epub 2019 Jun 12.

4.

Virtual reality of three-dimensional surgical field for surgical planning and intraoperative management.

Yamada Y, Inoue Y, Kaneko M, Fujihara A, Hongo F, Ukimura O.

Int J Urol. 2019 Sep;26(9):942-943. doi: 10.1111/iju.14047. Epub 2019 Jul 14. No abstract available.

PMID:
31302941
5.

Fulminant hepatitis as an immune-related adverse event after nivolumab treatment.

Inamori O, Miyagawa-Hayashino A, Ueno A, Hongo F, Sonobe Y, Hojo T, Konishi E.

Pathol Int. 2019 Jul;69(7):434-436. doi: 10.1111/pin.12812. Epub 2019 Jul 8. No abstract available.

PMID:
31286591
6.

Prostate cancer meeting the Japanese active surveillance criteria and diagnosed by community-based prostate-specific antigen screening: A 21-year follow-up study.

Hongo F, Okihara K, Kitamura K, Fujihara A, Yamada Y, Shiraishi T, Konishi E, Ukimura O.

Int J Urol. 2019 Aug;26(8):827-832. doi: 10.1111/iju.14037. Epub 2019 Jun 10.

PMID:
31183899
7.

Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program.

Kume H, Homma Y, Shinohara N, Obara W, Kondo T, Kimura G, Fujimoto H, Nonomura N, Hongo F, Sugiyama T, Takahashi M, Kanayama HO, Fukumori T, Eto M.

Jpn J Clin Oncol. 2019 Apr 12. pii: hyz054. doi: 10.1093/jjco/hyz054. [Epub ahead of print]

PMID:
30977820
8.

Magnetic resonance imaging/transrectal ultrasound fusion-targeted prostate biopsy using three-dimensional ultrasound-based organ-tracking technology: Initial experience in Japan.

Yamada Y, Fujihara A, Shiraishi T, Ueda T, Yamada T, Ueno A, Inoue Y, Kaneko M, Kamoi K, Hongo F, Okihara K, Ukimura O.

Int J Urol. 2019 May;26(5):544-549. doi: 10.1111/iju.13924. Epub 2019 Feb 21.

PMID:
30793385
9.

Individualized Dosing of Axitinib Based on First-Dose Area Under the Concentration-Time Curve for Metastatic Renal-Cell Carcinoma.

Miura Y, Imamura CK, Uchino K, Kishida T, Matsubara N, Shinojima T, Kondo K, Hongo F, Yoshimura K, Tanigawara Y, Takano T.

Clin Genitourin Cancer. 2019 Feb;17(1):e1-e11. doi: 10.1016/j.clgc.2018.09.015. Epub 2018 Sep 29.

PMID:
30529389
10.

Biochemical and magnetic resonance image response in targeted focal cryotherapy to ablate targeted biopsy-proven index lesion of prostate cancer.

Inoue Y, Ushijima S, Shiraishi T, Fujihara A, Hongo F, Ukimura O.

Int J Urol. 2019 Feb;26(2):317-319. doi: 10.1111/iju.13857. Epub 2018 Nov 28. No abstract available.

PMID:
30485553
11.

Ice Ball Crack During CT-Guided Renal Cryoablation Using 1.5-mm-Diameter Cryoprobes.

Ichijo Y, Miura H, Hirota T, Tanaka T, Yoshikawa T, Asai S, Hongo F, Ukimura O, Yamada K.

Cardiovasc Intervent Radiol. 2019 Mar;42(3):475-477. doi: 10.1007/s00270-018-2104-z. Epub 2018 Nov 1.

PMID:
30386882
12.

Preclinical orthotopic xenograft model of renal pelvis cancer in which cancer growth could be traced by an in vivo imaging system.

Shimizu T, Miyashita M, Fujihara A, Hongo F, Ukimura O, Ashihara E.

Int J Urol. 2019 Jan;26(1):138-139. doi: 10.1111/iju.13829. Epub 2018 Oct 11. No abstract available.

PMID:
30308707
13.

MRGBP promotes AR-mediated transactivation of KLK3 and TMPRSS2 via acetylation of histone H2A.Z in prostate cancer cells.

Ito S, Kayukawa N, Ueda T, Taniguchi H, Morioka Y, Hongo F, Ukimura O.

Biochim Biophys Acta Gene Regul Mech. 2018 Aug 1. pii: S1874-9399(18)30068-3. doi: 10.1016/j.bbagrm.2018.07.014. [Epub ahead of print]

PMID:
30076933
14.

Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma.

Hagiwara N, Watanabe M, Iizuka-Ohashi M, Yokota I, Toriyama S, Sukeno M, Tomosugi M, Sowa Y, Hongo F, Mikami K, Soh J, Fujito A, Miyashita H, Morioka Y, Miki T, Ukimura O, Sakai T.

Cancer Lett. 2018 Sep 1;431:182-189. doi: 10.1016/j.canlet.2018.05.025. Epub 2018 May 17.

PMID:
29778569
15.

Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients.

Inoue Y, Nakamura T, Nakanishi H, Oishi M, Hongo F, Okihara K, Mizutani S, Kuroda J, Ukimura O.

Int J Urol. 2018 Jul;25(7):678-683. doi: 10.1111/iju.13597. Epub 2018 May 11.

16.

Comparison of neutrophil distribution patterns in Jordans' anomaly among major automated hematology analyzers.

Inaba T, Ishizuka K, Suzuki A, Yuasa S, Saito K, Kodama M, Hongo F, Fujita N, Hirano K.

Int J Lab Hematol. 2018 Aug;40(4):e78-e81. doi: 10.1111/ijlh.12842. Epub 2018 Apr 30. No abstract available.

PMID:
29708306
17.

CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells.

Ito S, Ueno A, Ueda T, Nakagawa H, Taniguchi H, Kayukawa N, Fujihara-Iwata A, Hongo F, Okihara K, Ukimura O.

Oncotarget. 2018 Apr 3;9(25):17645-17655. doi: 10.18632/oncotarget.24824. eCollection 2018 Apr 3.

18.

Active heavy cigarette smoking is associated with poor survival in Japanese patients with advanced renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association.

Hara T, Fujimoto H, Kondo T, Shinohara N, Obara W, Kimura G, Kume H, Nonomura N, Hongo F, Sugiyama T, Kanayama HO, Takahashi M, Fukumori T, Eto M; Cancer Registration Committee of the Japanese Urological Association.

Jpn J Clin Oncol. 2017 Dec 1;47(12):1162-1169. doi: 10.1093/jjco/hyx129.

PMID:
29121328
21.

CNPY2 promoted the proliferation of renal cell carcinoma cells and increased the expression of TP53.

Taniguchi H, Ito S, Ueda T, Morioka Y, Kayukawa N, Ueno A, Nakagawa H, Fujihara A, Ushijima S, Kanazawa M, Hongo F, Ukimura O.

Biochem Biophys Res Commun. 2017 Apr 1;485(2):267-271. doi: 10.1016/j.bbrc.2017.02.095. Epub 2017 Feb 21.

PMID:
28235487
22.

Morphometric analysis of prostate zonal anatomy using magnetic resonance imaging: impact on age-related changes in patients in Japan and the USA.

Matsugasumi T, Fujihara A, Ushijima S, Kanazawa M, Yamada Y, Shiraishi T, Hongo F, Kamoi K, Okihara K, de Castro Abreu AL, Oishi M, Shin T, Palmer S, Gill IS, Ukimura O.

BJU Int. 2017 Oct;120(4):497-504. doi: 10.1111/bju.13823. Epub 2017 Mar 24.

23.

Preoperative lipiodol marking and its role on survival and complication rates of CT-guided cryoablation for small renal masses.

Hongo F, Yamada Y, Ueda T, Nakmura T, Naya Y, Kamoi K, Okihara K, Ichijo Y, Miki T, Yamada K, Ukimura O.

BMC Urol. 2017 Jan 18;17(1):10. doi: 10.1186/s12894-017-0199-1.

24.
25.

Basic utility of Pentra series automated hematology analyzer for screening of Jordans' anomaly.

Inaba T, Ishizuka K, Suzuki A, Yuasa S, Saito K, Kodama M, Hamada M, Hongo F, Fujita N, Hirano KI.

Int J Lab Hematol. 2017 Feb;39(1):e1-e3. doi: 10.1111/ijlh.12570. Epub 2016 Aug 30. No abstract available.

PMID:
27572746
26.

Androgen suppresses testicular cancer cell growth in vitro and in vivo.

Nakagawa H, Ueda T, Ito S, Shiraishi T, Taniguchi H, Kayukawa N, Nakanishi H, Ushijima S, Kanazawa M, Nakamura T, Naya Y, Hongo F, Kamoi K, Okihara K, Ukimura O.

Oncotarget. 2016 Jun 7;7(23):35224-32. doi: 10.18632/oncotarget.9109.

27.

Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction.

Low SK, Fukunaga K, Takahashi A, Matsuda K, Hongo F, Nakanishi H, Kitamura H, Inoue T, Kato Y, Tomita Y, Fukasawa S, Tanaka T, Nishimura K, Uemura H, Hara I, Fujisawa M, Matsuyama H, Hashine K, Tatsugami K, Enokida H, Kubo M, Miki T, Mushiroda T.

PLoS One. 2016 Feb 25;11(2):e0148177. doi: 10.1371/journal.pone.0148177. eCollection 2016.

28.

Transvesical laparoscopic surgery for double renal pelvis and ureter with or without ureterocele.

Naitoh Y, Oishi M, Kobayashi K, Yamada Y, Nakamura T, Johnin K, Hongo F, Naya Y, Okihara K, Kawauchi A.

Int J Urol. 2016 Apr;23(4):332-6. doi: 10.1111/iju.13049. Epub 2016 Feb 14.

29.

Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.

Nakamura T, Kawauchi A, Oishi M, Ueda T, Shiraishi T, Nakanishi H, Kamoi K, Naya Y, Hongo F, Okihara K, Miki T.

Int J Clin Oncol. 2016 Aug;21(4):791-795. doi: 10.1007/s10147-015-0934-0. Epub 2015 Dec 23.

PMID:
26701172
30.

Predictive factors for sorafenib-induced hand-foot skin reaction using ordered logistic regression analysis.

Kanbayashi Y, Hosokawa T, Yasui K, Hongo F, Yamaguchi K, Moriguchi M, Miki T, Itoh Y.

Am J Health Syst Pharm. 2016 Jan 1;73(1):e18-23. doi: 10.2146/ajhp150129. Erratum in: Am J Health Syst Pharm. 2016 Feb 15;73(4):186.

PMID:
26683674
31.

Laparoendoscopic Single-Site Surgery for Pediatric Urologic Disease.

Yamada Y, Naitoh Y, Kobayashi K, Fujihara A, Johnin K, Hongo F, Naya Y, Kamoi K, Okihara K, Kawauchi A, Miki T.

J Endourol. 2016 Jan;30(1):24-7. doi: 10.1089/end.2015.0130. Epub 2015 Oct 27.

PMID:
26411287
32.

PAX2 promoted prostate cancer cell invasion through transcriptional regulation of HGF in an in vitro model.

Ueda T, Ito S, Shiraishi T, Taniguchi H, Kayukawa N, Nakanishi H, Nakamura T, Naya Y, Hongo F, Kamoi K, Okihara K, Kawauchi A, Miki T.

Biochim Biophys Acta. 2015 Nov;1852(11):2467-73. doi: 10.1016/j.bbadis.2015.08.008. Epub 2015 Aug 19.

33.

Laparoscopic off-clamp partial nephrectomy using soft coagulation.

Hongo F, Kawauchi A, Ueda T, Fujihara-Iwata A, Nakamura T, Naya Y, Kamoi K, Okihara K, Miki T.

Int J Urol. 2015 Aug;22(8):731-4. doi: 10.1111/iju.12808. Epub 2015 May 18.

34.

The efficacy of radio-frequency ablation for metastatic lung or liver tumors of male germ cell tumors as an alternative minimally invasive therapy after salvage chemotherapy.

Naya Y, Nakamura T, Oishi M, Ueda T, Nakanishi H, Naitoh Y, Hongo F, Kamoi K, Okihara K, Tanaka O, Yamagami T, Yamada K, Miki T.

Int J Clin Oncol. 2015 Dec;20(6):1192-7. doi: 10.1007/s10147-015-0824-5. Epub 2015 Apr 30.

PMID:
25924698
35.

Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses.

Nakamura T, Oishi M, Ueda T, Fujihara A, Nakanishi H, Kamoi K, Naya Y, Hongo F, Okihara K, Miki T.

Int J Urol. 2015 Jul;22(7):663-8. doi: 10.1111/iju.12760. Epub 2015 Apr 6.

36.

Importance of continuous sequential chemotherapy and multimodal treatment for advanced testicular cancer: a high-volume Japanese center experience.

Nakamura T, Ueda T, Oishi M, Nakanishi H, Shiraishi T, Fujihara A, Naito Y, Kamoi K, Naya Y, Hongo F, Okihara K, Miki T.

Medicine (Baltimore). 2015 Mar;94(11):e653. doi: 10.1097/MD.0000000000000653.

37.

CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence.

Hongo F, Takaha N, Oishi M, Ueda T, Nakamura T, Naitoh Y, Naya Y, Kamoi K, Okihara K, Matsushima T, Nakayama S, Ishihara H, Sakai T, Miki T.

Urol Oncol. 2014 Nov;32(8):1240-6. doi: 10.1016/j.urolonc.2014.05.006. Epub 2014 Nov 14.

38.

Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors.

Nakamura T, Ueda T, Oishi M, Nakanishi H, Fujihara A, Naya Y, Hongo F, Kamoi K, Okihara K, Miki T.

Int J Urol. 2015 Mar;22(3):288-93. doi: 10.1111/iju.12665. Epub 2014 Nov 13.

39.

Differences in adverse event profiles between everolimus and temsirolimus and the risk factors for non-infectious pneumonitis in advanced renal cell carcinoma.

Nozawa M, Ohzeki T, Tamada S, Hongo F, Anai S, Fujimoto K, Miki T, Nakatani T, Fukasawa S, Uemura H.

Int J Clin Oncol. 2015 Aug;20(4):790-5. doi: 10.1007/s10147-014-0764-5. Epub 2014 Oct 25.

PMID:
25342378
40.

Experience of laparoscopic partial nephrectomy using a kidney grasper in selective cases.

Hongo F, Kawauchi A, Itoh Y, Fujii H, Naitoh Y, Nakamura T, Naya Y, Kamoi K, Okihara K, Miki T.

J Laparoendosc Adv Surg Tech A. 2014 Nov;24(11):795-8. doi: 10.1089/lap.2014.0212. Epub 2014 Oct 14.

PMID:
25313443
41.

Percutaneous nephrolithotripsy and antegrade ureterolithotripsy in a 10-month-old infant with urinary stones in both kidney and ureter.

Naitoh Y, Yamada Y, Fujihara A, Naya Y, Hongo F, Kamoi K, Okihara K, Miki T.

Int J Urol. 2015 Jan;22(1):128-30. doi: 10.1111/iju.12626. Epub 2014 Sep 23.

42.

Initial experience of combined use of photodynamic diagnosis and narrow band imaging for detection of flat urothelial lesion.

Naya Y, Oishi M, Yamada Y, Ueda T, Fujihara A, Nakanishi H, Naito Y, Nakamura T, Hongo F, Kamoi K, Okihara K, Miki T.

Int J Clin Oncol. 2015 Jun;20(3):593-7. doi: 10.1007/s10147-014-0748-5. Epub 2014 Sep 18.

PMID:
25228479
43.

Paired box 2 upregulates androgen receptor gene expression in androgen-independent prostate cancer.

Ito S, Ueda T, Ueno A, Nakagawa H, Taniguchi H, Hongo F, Kamoi K, Okihara K, Kawauchi A, Miki T.

FEBS J. 2014 Oct;281(19):4506-18. doi: 10.1111/febs.12959. Epub 2014 Aug 26.

44.

Complete response of sunitinib therapy for renal cell cancer recurrence in the native kidney after renal transplantation: a case report.

Hongo F, Oishi M, Ueda T, Naitoh Y, Nakamura T, Naya Y, Kamoi K, Okihara K, Miki T.

BMC Res Notes. 2014 Aug 13;7:526. doi: 10.1186/1756-0500-7-526.

45.

Long-term outcome of hand-assisted laparoscopic radical nephrectomy for T1 renal cell carcinoma.

Hongo F, Kawauchi A, Ueda T, Fujihara A, Naitoh Y, Nakamura T, Naya Y, Kamoi K, Okihara K, Miki T.

Int J Urol. 2014 Nov;21(11):1093-6. doi: 10.1111/iju.12551. Epub 2014 Jul 14.

46.

Comparison of diameter-axial-polar nephrometry and RENAL nephrometry score for treatment decision-making in patients with small renal mass.

Naya Y, Kawauchi A, Oishi M, Ueda T, Fujihara A, Naito Y, Nakamura T, Hongo F, Kamoi K, Okihara K, Miki T.

Int J Clin Oncol. 2015 Apr;20(2):358-61. doi: 10.1007/s10147-014-0714-2. Epub 2014 Jun 27.

PMID:
24964973
47.

Laparoendoscopic single-site versus conventional laparoscopic pyeloplasty: a matched pair analysis.

Naitoh Y, Kawauchi A, Yamada Y, Fujihara A, Hongo F, Kamoi K, Okihara K, Miki T.

Int J Urol. 2014 Aug;21(8):793-6. doi: 10.1111/iju.12427. Epub 2014 Mar 25.

48.

Nephrolithotomy performed concurrently with laparoendoscopic single-site pyeloplasty.

Naitoh Y, Kawauchi A, Kamoi K, Soh J, Hongo F, Okihara K, Miki T.

Urology. 2014 Jan;83(1):243-6. doi: 10.1016/j.urology.2013.08.051. Epub 2013 Oct 19.

PMID:
24149107
49.

Hyper-expression of PAX2 in human metastatic prostate tumors and its role as a cancer promoter in an in vitro invasion model.

Ueda T, Ito S, Shiraishi T, Kulkarni P, Ueno A, Nakagawa H, Kimura Y, Hongo F, Kamoi K, Kawauchi A, Miki T.

Prostate. 2013 Sep;73(13):1403-12. doi: 10.1002/pros.22687. Epub 2013 Jun 14. Erratum in: Prostate. 2014 Apr;74(4):450.

PMID:
23765687
50.

Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.

Kimura Y, Nakamura T, Kawauchi A, Kawabata G, Hongo F, Miki T.

Int J Urol. 2013 Aug;20(8):837-41. doi: 10.1111/iju.12072. Epub 2013 Jan 10.

Supplemental Content

Support Center